Associate Professor of Management
Dr. Hyunsung D. Kang received his Ph.D. in strategic management from the Georgia Institute of Technology, and spent the past several years as a visiting professor at Georgia Tech and an assistant professor of management at Adelphi University. He joined the management faculty of Campbell School of Business at Berry College in 2016. His research interests center primarily on firm strategy and the performance implications of R&D investment decisions. This includes understanding the interrelationship between firm performance and the use of external technology markets through corporate venture capital, licensing, acquisitions, alliances, and internal R&D. Dr. Kang is also the recipient of several teaching and research awards, including Beta Gamma Sigma Professor of the Year, Coller Senior Awards from Tel Aviv University, Israel, and Outstanding Scholar Awards from the Campbell School of Business.
Education
- Ph.D. Strategic Management, Georgia Institute of Technology, 2012
Teaching Interests
- Strategic Management
- Technology/Innovation Management
- Entrepreneurship
Research Interests
- Corporate strategy
- Technology/Innovation/R&D management
- Entrepreneurial finance
Field Experience
- Founder and Corporate Venture Capitalist (Information Technology)
- Consultant (Finance/Automobiles)
Selected Publications
-
Kang, H., Nanda, V., Park, H., 2021. Technology spillovers and capital gains in corporate venture capital investments: Evidence from the biopharmaceutical industry. Venture Capital: An International Journal of Entrepreneurial Finance, 23(2): 129-155. †
-
Kang, H., Edelman, E.R., Ku, D., 2019. Who creates jobs? Venture capital, research grants, and regional employment in the U.S. Industry and Innovation, 26(6): 690-714. †
-
Ceccagnoli, M., Higgins, M.J., Kang, H., 2018. Corporate venture capital as a real option in the market for technology. Strategic Management Journal, 39(13): 3355-3381. †
-
Kang, H., 2018. A start-up’s technology as a determinant of its financing source: Evidence from the biopharmaceutical industry. Journal of Pharmaceutical Innovation, 13(4): 301-312. ††
-
Kang, H., 2018. A start-up’s R&D stages and the evolution of financing sources: Evidence from the biotechnology industry. Entrepreneurship Research Journal, 8(3): 1-19. †
-
Kang, H., Ku, D., Edelman, E.R., 2017. Differential effects of public and private funding in the medical device industry. Expert Review of Medical Devices, 15(2): 91-98. ††
-
Kang, H., Lee, J., 2016. Scientific celebrity, competition, and knowledge creation: The case of stem cell research in South Korea. Journal of Engineering and Technology Management, 39(January–March): 26-44. †
† SSCI (Social Sciences Citation Index)
†† SCI (Sciences Citation Index)